This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greatbatch Announces Engagement To Advance Medical Device Strategy

Greatbatch, Inc. announced the company has engaged Abel Ang as senior advisor to Greatbatch President and CEO, Thomas J. Hook. In that role, Ang will provide guidance relative to the commercialization of QiG medical device technologies into the health care markets of emerging countries and also help to advise on Greatbatch’s expansion into Asia.

“In 2008, Greatbatch launched a strategy to move our company forward and evolve from not only being an innovative component manufacturer but also being an innovative medical device company,” said Thomas J. Hook, President and CEO. “Abel’s background and experience will serve the company well as we continue our evolution and look to partner with entities in emerging markets to execute our strategy.”

Abel Ang was formerly President, Asia/Pacific for Hill-Rom Inc, a medical devices company, where he was responsible for expanding Hill-Rom’s presence in the high growth Asia/Pacific markets. He previously served as the Chief Technology Officer for Hill-Rom, where he had overall responsibility for Hill-Rom’s global R&D operations distributed across sites in the U.S., Mexico, France, and Singapore. He was also Vice-President and General Manager of Hill-Rom’s $420M Global Surfaces and Therapy Business Unit in addition to other business development positions with the company.

Prior to joining Hill-Rom, Ang headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s (EDB) Biomedical Division and spent several years in EDB’s European Operations based in Frankfurt, Germany. He currently sits on the Board of Exploit Technologies which provides access to Singapore's largest pool of intellectual property and knowledge generated by over 2,000 researchers at A*STAR's research institutes, and on the Advisory Board of the Singapore-MIT Alliance Innovation Grant.

About Greatbatch, Inc.

Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs